Back to XERS
D. E. Shaw & Co., Inc. XERS Position History
Xeris Biopharma Holdings, Inc. • Healthcare
Quarters held
22
Latest value
$7.8M
Q2 2026
Peak value
$54.9M
First seen
Q2 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2022 | $75K |
| Q3 2022 | $245K |
| Q4 2022 | $216K |
| Q4 2023 | $2.5M |
| Q1 2024 | $1.4M |
| Q1 2024 | $152K |
| Q2 2024 | $718K |
| Q2 2024 | $448K |
| Q3 2024 | $2.4M |
| Q3 2024 | $365K |
| Q4 2024 | $4.4M |
| Q4 2024 | $176K |
| Q1 2025 | $16.8M |
| Q2 2025 | $17.9M |
| Q3 2025 | $47.2M |
| Q3 2025 | $302K |
| Q4 2025 | $54.9M |
| Q4 2025 | $4.6M |
| Q1 2026 | $41.1M |
| Q1 2026 | $4M |
| Q2 2026 | $54M |
| Q2 2026 | $7.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $7.8M | 986.3K | — | — |
| Q2 2026 | $54M | 6.82M | — | — |
| Q1 2026 | $4M | 696.0K | — | — |
| Q1 2026 | $41.1M | 7.09M | — | — |
| Q4 2025 | $4.6M | 582.0K | — | — |
| Q4 2025 | $54.9M | 6.99M | — | — |
| Q3 2025 | $302K | 37.1K | — | — |
| Q3 2025 | $47.2M | 5.80M | — | — |
| Q2 2025 | $17.9M | 3.84M | — | — |
| Q1 2025 | $16.8M | 3.05M | — | — |
| Q4 2024 | $176K | 52.0K | — | — |
| Q4 2024 | $4.4M | 1.31M | — | — |
| Q3 2024 | $365K | 128.2K | — | — |
| Q3 2024 | $2.4M | 856.8K | — | — |
| Q2 2024 | $448K | 199.1K | — | — |
| Q2 2024 | $718K | 318.9K | — | — |
| Q1 2024 | $152K | 68.9K | — | — |
| Q1 2024 | $1.4M | 638.1K | — | — |
| Q4 2023 | $2.5M | 1.05M | — | — |
| Q4 2022 | $216K | 162.4K | — | — |
| Q3 2022 | $245K | 157.3K | — | — |
| Q2 2022 | $75K | 48.9K | — | — |